Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4803
Gene Symbol: NGF
NGF 		0.300 Therapeutic phenotype CTD_human Reduction of ischemic damage in NGF-transgenic mice: correlation with enhancement of antioxidant enzyme activities. 10408807 1999
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.300 Therapeutic phenotype CTD_human Massive cerebral edema after recanalization post-thrombolysis. 11677890 2001
Entrez Id: 5327
Gene Symbol: PLAT
PLAT 		0.300 Therapeutic phenotype CTD_human Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. 12297567 2002
Entrez Id: 6347
Gene Symbol: CCL2
CCL2 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 467
Gene Symbol: ATF3
ATF3 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 2353
Gene Symbol: FOS
FOS 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 7130
Gene Symbol: TNFAIP6
TNFAIP6 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 6347
Gene Symbol: CCL2
CCL2 		0.300 Therapeutic phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 7498
Gene Symbol: XDH
XDH 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 5337
Gene Symbol: PLD1
PLD1 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 3329
Gene Symbol: HSPD1
HSPD1 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 6354
Gene Symbol: CCL7
CCL7 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 3569
Gene Symbol: IL6
IL6 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 871
Gene Symbol: SERPINH1
SERPINH1 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 2920
Gene Symbol: CXCL2
CXCL2 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 3383
Gene Symbol: ICAM1
ICAM1 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 3726
Gene Symbol: JUNB
JUNB 		0.300 Biomarker phenotype CTD_human A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. 12374626 2002
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.300 Therapeutic phenotype CTD_human [Effectiveness of urokinase used in combination with batroxobin (DF-521) in rat model of focal cerebral ischemia-reperfusion]. 15181847 2004
Entrez Id: 1906
Gene Symbol: EDN1
EDN1 		0.300 Biomarker phenotype CTD_human Detrimental effects of halothane narcosis on damage after endothelin-1-induced MCAO. 17197033 2007
Entrez Id: 5327
Gene Symbol: PLAT
PLAT 		0.300 Therapeutic phenotype CTD_human Assessment of suitability of thrombolysis in middle cerebral artery infarction: a proof of concept study of a stereologically-based technique. 17690543 2007
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.300 Therapeutic phenotype CTD_human Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. 17702958 2007
Entrez Id: 5327
Gene Symbol: PLAT
PLAT 		0.300 Therapeutic phenotype CTD_human [Orolingual angioedema as complication after rt-PA in stroke patient treated with ACE inhibitor]. 18453163 2008
Entrez Id: 240
Gene Symbol: ALOX5
ALOX5 		0.300 Biomarker phenotype CTD_human 5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9. 19309543 2009
Entrez Id: 4318
Gene Symbol: MMP9
MMP9 		0.300 Biomarker phenotype CTD_human 5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9. 19309543 2009
Entrez Id: 5327
Gene Symbol: PLAT
PLAT 		0.300 Therapeutic phenotype CTD_human Neurological picture. Orolingual angio-oedema after alteplase therapy in a stroke patient concurrently using angiotensin II receptor blocker. 20547619 2010